Dermatology Medical News about urticaria

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo- controlled treatment with rupatadine 10 and 20 mg
Journal of the European Academy of Dermatology and Venereology, 08/10/09

Giménez–Arnau A et al. – The results support the use of higher than standard doses of non sedating antihistamines in chronic urticaria. The authors strongly recommend performing and reporting responder analyses for established and new drugs used by patients with chronic urticaria.

<< Previous
Psychological burden of anogenital warts

Next >>
Strip patch test vs. conventional patch test: investigation of...